Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)

Biofil Chemicals Pharmaceuticals BCPL is one of India's leading producers of pharmaceutical products. Established in 1985 as a private limited company, BCPL eventually converted to become public limited in 1992. Supported by the Systematix group and Ramesh Shah of the Cyano Group, Ramesh Shah is the Chairman and Managing Director while Anand Kumar Sethiya is the Managing Director. To finance expansion and diversification, BCPL launched a rights cum public issue at a premium of Rs 7.50 and Rs 12.50 in 1996, worth Rs 23.21 crore. Currently, BCPL manufactures pharmaceutical formulations like injections, capsules, eyedrops, and dry syrups at its Indore plant. Furthermore, a new unit is being set up at Pithampur in Madhya Pradesh with a budget of Rs. 39.75 crore to manufacture bulk drugs such as astemizole, cefaclor, pentazocine, and cefotoxime sodium. Additionally, a research and development (R&D) centre is being established, housing a pilot plant for bulk drugs and separate sections for formulation development as well as modern analytical instruments. In the year 19992000, BCPL reported a total turnover of Rs.1164.03 lakhs.

Share Price: ₹63.76 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹103.23Cr as of today
Listing date: 12 Jun, 1996
Chairperson Name: Ramesh Shah